Page last updated: 2024-09-03
ly 243670 and dextroamphetamine
ly 243670 has been researched along with dextroamphetamine in 1 studies
Compound Research Comparison
Studies (ly 243670) | Trials (ly 243670) | Recent Studies (post-2010) (ly 243670) | Studies (dextroamphetamine) | Trials (dextroamphetamine) | Recent Studies (post-2010) (dextroamphetamine) |
---|---|---|---|---|---|
14 | 0 | 2 | 7,044 | 697 | 660 |
Protein Interaction Comparison
Protein | Taxonomy | ly 243670 (IC50) | dextroamphetamine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.631 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.2884 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Shaw, WN | 1 |
Other Studies
1 other study(ies) available for ly 243670 and dextroamphetamine
Article | Year |
---|---|
Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants.
Topics: Albuterol; Animals; Appetite Depressants; Cyclohexanes; Dextroamphetamine; Drug Tolerance; Eating; Endorphins; Female; Fenfluramine; Injections, Subcutaneous; Male; Naltrexone; Obesity; Piperidines; Rats; Rats, Zucker; Weight Gain | 1993 |